VASCULAR BIRTHMARKS FOUNDATION INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1994

Legal Domicile

Principal Officer

DR LINDA ROZELL-SHANNON

Phone

5187829637

Tax Period

2025-01-01 to 2025-12-31

VASCULAR BIRTHMARKS FOUNDATION INC, founded in 1994, is a small nonprofit in the Diseases & Disorders sector that reported $623K in total revenue in fiscal year 2025. Expenses of $564K left a modest 9% surplus.

Mission

PROVIDE SUPPORT AND INFORMATIONAL RESOURCES FOR INDIVIDUALS AFFECTED BY HEMANGIOMAS, PORT WINE STAINS AND OTHER VASCULAR BIRTHMARKS AND TUMORS, AND SPONSORED RELEVANT RESEARCH

Program Service Accomplishments

Program 1

Expenses: $322,609

PROVIDE SUPPORT AND INFORMATIONAL RESOURCES FOR INDIVIDUALS AFFECTED BY HEMANGIOMAS, PORT WINE STAINS AND OTHER VASCULAR BIRTHMARKS AND TUMORS, AND SPONSORED RELEVANT RESEARCH

Program 2

Expenses: $14,531 Revenue: $128,855

TO EDUCATE THE PUBLIC ON VASCULAR BIRTHMARKS THROUGH THE ANNUAL CONFERENCE AND TO PROVIDE SERVICES TO GUESTS.

Program 3

Expenses: $11,000 Revenue: $3,500

AWARD SCHOLARSHIPS TO INDIVIDUALS WITH VASCULAR BIRTHMARKS WHO ARE PRODUCTIVE IN THEIR COMMUNITIES AND SCHOOLS AND WHO AGREE TO PROMOTE THE VBF ON CAMPUS. THE ABBY CIZIRR PHYSICIAN GRANT WAS ALSO...

AWARD SCHOLARSHIPS TO INDIVIDUALS WITH VASCULAR BIRTHMARKS WHO ARE PRODUCTIVE IN THEIR COMMUNITIES AND SCHOOLS AND WHO AGREE TO PROMOTE THE VBF ON CAMPUS. THE ABBY CIZIRR PHYSICIAN GRANT WAS ALSO AWARDED TO GIVE PHYSICIAN RECIPIENTS THE OPPORTUNITY TO FURTHER THEIR STUDIES ON VASCULAR BIRTHMARKS. THE WEBER FUND WAS ESTABLISHED TO HELP NEEDY FAMILIES PAY FOR TRAVEL EXPENSES IN CONNECTION TO KLIPPEL-TRENAUNAY SYNDROME.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $448,816

Program Service Revenue $128,855

Investment Income $43,001

Other Revenue $2,540

TOTAL REVENUE $623,212

Expense Breakdown

Grants Paid $11,000

Salaries & Benefits $334,068

Fundraising Expenses $67,548

Program Expenses $348,140

Other Expenses $219,351

TOTAL EXPENSES $564,419

Year-over-Year Comparison

	2025	2024	Change
Revenue	$623,212	$586,808	+0.1%
Expenses	$564,419	$599,067	-0.1%
Net Income	$58,793	$-12,259	-5.8%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$91,349

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DR LINDA ROZELL-SHANNON	Executive Dir.	32.00	Officer	$91,349	$0	$91,349
AILEE MARTYNOWSKI	Secretary	2.00	Officer Director	$0	$0	$0
JESSICA FAGAN PSYD	PATIENT ADVOCAT	2.00	Director	$0	$0	$0
J STUART NELSON MD PHD	Director	2.00	Director	$0	$0	$0
CHRISTINE SOKOL	PATIENT ADVOCAT	2.00	Director	$0	$0	$0
MICHELLE SARIO	FUNDRAISING	2.00	Director	$0	$0	$0
ROY G GERONEMUS MD	Director	2.00	Director	$0	$0	$0
GIACOMO COLLETTI MD	Director	2.00	Director	$0	$0	$0
MELANIE CARTER	PATIENT ADVOCAT	2.00	Director	$0	$0	$0
FRED SIYUFY	PATIENT ADVOCAT	2.00	Director	$0	$0	$0
SAMANTHA DRAZIN LMHC	Chairman	2.00	Director	$0	$0	$0
TRITIA MEDRANO	PATIENT ADVOCAT	2.00	Director	$0	$0	$0
DONNA WATSON	PATIENT ADVOCAT	0.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$623,212	$564,419	$1,189,819	$58,793
2024	$586,808	$599,067	$1,126,410	$-12,259
2023	$602,102	$589,656	$1,134,010	$12,446
2022	$562,743	$494,414	$1,102,465	$68,329
2021	$620,340	$433,192	$1,063,742	$187,148
2020	$402,918	$318,652	$913,973	$84,266
2019	$298,459	$435,493	$790,227	$-137,034
2018	$602,189	$428,544	$925,291	$173,645